FOR HEALTHCAREPROFESSIONALS
Thank you for visiting the XIFAXAN Professional website. By clicking OK, you will be taken to a website or sites where our Privacy Policy and other rules do not apply. Salix Pharmaceuticals does not possess editorial control over the content of the information on such website(s) and therefore does not warrant their accuracy and completeness. You are solely responsible for interactions with such website(s).
The resources below include information about dosing, insurance requirements,* and the science behind XIFAXAN. You’ll also find materials to share with your patients to help them understand treatment with XIFAXAN and keep track of their IBS-D symptoms.
Find dosing information for IBS-D and overt HE indications on this at-a-glance card.
Understand a cause affecting many IBS-D patients and how XIFAXAN may work to relieve symptoms.
Keep easy-to-follow directions on-hand to help make PA submissions simple for XIFAXAN. Includes both IBS-D and HE indications.
A standard form for a patient‐specific letter of medical necessity to explain your clinical decision-making in choosing a therapy.
A Tier Exception request to reduce the cost-share of a medication. Follows submission of a PA or Utilization Management request.
IBS-D = irritable bowel syndrome with diarrhea.
HE = hepatic encephalopathy.
*Salix Pharmaceuticals does not guarantee coverage or reimbursement for the product.
Keep patients informed about what it means to have and treat IBS-D with XIFAXAN.
Ask patients to track diet and IBS-D symptoms to aid your in-office discussions.
Available for eligible,† commercially insured patients.
†Patient is not eligible if he/she participates in or seeks reimbursement or submits a claim for reimbursement to any federal or state healthcare program with prescription drug coverage, such as Medicaid, Medicare, Medigap, VA, DOD, TRICARE, or any similar federal or state health care program (each a Government Program), or where prohibited by law. Patient must be enrolled in, and must seek reimbursement from or submit a claim for reimbursement to, a commercial insurance plan. Offer excludes full cash-paying patients. Maximum benefits and other restrictions apply. Visit https://xifaxan.copaysavingsprogram.com/ or call 1-866-XIFAXAN for full eligibility criteria, terms and conditions.
Get information regarding XIFAXAN
Speak with a XIFAXAN representative
XIFAXAN® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults.